Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Neuroblastoma cell lines treated with DAC (2'-deoxy-5-azacytidine), a DNA-methylation inhibitor
PubMed Full text in PMC Similar studies Analyze with GEO2R
A genome wide methylation map of neuroblastoma cell lines
Methylation map of 8 neuroblastoma cell lines: NGS after MBD2-capture
PubMed Full text in PMC Similar studies SRA Run Selector
Methyl-CpG-binding domain (MBD) sequencing of neuroblastoma tumors
PubMed Full text in PMC Similar studies
Methyl-CpG-binding domain (MBD) sequencing of 15 primary stage 4S neuroblastoma tumors
Methyl-CpG-binding domain (MBD) sequencing of 45 primary neuroblastoma tumors
Methyl-CpG-binding domain (MBD) sequencing of 42 primary neuroblastoma tumors
Analysis of genome-wide methylation and gene expression induced by decitabine treatment in HL60 leukemia cell line
PubMed Similar studies Analyze with GEO2R
Genome-wide methylation and expression profiling study identifies candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer.
Genome-wide Methylation Profiling Identifies Candidate DNA Methylation Drivers of Acquired Cisplatin Resistance in Ovarian Cancer.
Gene expression profiling in A2780, CP70 and CP70 following Decitabine and/or PXD101 treatment
Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma
Genome-wide methylation profiling of ovarian cancer patient-derived xenograft (PDXs) treated with the demethylating agent decitabine identifies novel epigenetically regulated genes and pathways
5-aza-2-deoxycytidine treatment of Swarm rat chondrosarcoma cells
Random forest-based modelling to detect novel biomarkers for prostate cancer progression
Genome-wide screen for promoter methylation in NSCLC identifies novel methylation markers for multiple malignancies
A Genome-wide Screen for Hypermethylated Genes in Lung Cancer
DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma.
DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [gene expression]
DNA methylation changes at CpG and non-CpG sites are associated with development and clinical behavior in neuroblastoma [methylation]
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on